|
|
Article: ATROVENT NASAL SPRAY IS THE FIRST MEDICATION IN A NEW CLASS OF NASAL SPRAYS TO RELIEVE A RUNNY NOSE
- Article from:
- PR Newswire
- Article date:
- February 1, 1996
|
Copyright informationCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Relief is Here for Millions Who Suffer from
Runny Nose Due to Allergies and Colds
RIDGEFIELD, Conn., Feb. 1 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals today issued the following:
Atrovent(R) (ipratropium bromide) Nasal Spray today became available as the first medication in a new class of nasal sprays to relieve runny noses (rhinorrhea) associated with year-round allergies, and nonallergic reactions (for which there is no known allergic cause), as well as the common cold. Atrovent Nasal Spray comes in two strengths: 0.3% for the runny nose associated with the allergic and nonallergic conditions, and .06% for the common cold.
...
Related newspaper, magazine, and journal articles:
|